The Poonawalla Vaccines Research Building is to be established at Oxford University following £50m funding commitment from Serum Life Sciences.
  • £50 million donation will see physical creation of a new building on Old Road Campus, Oxfor
  •  The building will be a new home for the world-class Jenner Institute team behind the Oxford University/AstraZeneca COVID-19 vaccine, and other leading Oxford teams such as those developing a malaria vaccine
  • The donation will be the University of Oxford’s largest ever gift for vaccines research

Oxford University last week announced a £50m funding commitment from Serum Life Sciences Ltd to establish The Poonawalla Vaccines Research Building at the University of Oxford.

Serum Life Sciences is wholly-owned by the Poonawalla family, owners of the Serum Institute of India, who have dedicated their life’s work to the development, manufacture and supply of affordable vaccines to low- and middle-income countries.

The Poonawalla Vaccines Research Building will be built on the same site as the recently announced Oxford University Pandemic Sciences Centre, on the University’s Old Road Campus. The buildings will share infrastructure and support facilities for scientific research and academic teaching and together will form a unique hub that will significantly contribute to global pandemic preparedness and responsiveness.

The main focus of the research taking place in the Poonawalla Building will be vaccinology. This new facility will house over 300 research scientists and itself will provide the focus and scale for the University’s major vaccine development programmes allowing a rapid, productive and timely expansion of this fast-growing translational area.

Please click here for the full story.